Mibavademab
Mibavademab is a CHO-expressed humanized antibody that targets LEPR/CD295. Mibavademab is equipped with a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.58 kDa. The isotype control for Mibavademab can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003) .
Product Specifications
CAS Number
[2305770-44-7]
UNSPSC
12352203
Target
Neuropeptide Y Receptor
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mibavademab.html
Purity
99.90
Molecular Weight
(145.58 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1055372-01 0.02 mg (E-Coli)
Recombinant Pelotomaculum thermopropionicum LexA repressor (lexA)
Ask
View Details MBS1055372-02 0.1 mg (E-Coli)
Recombinant Pelotomaculum thermopropionicum LexA repressor (lexA)
Ask
View Details 
MBS1055372-03 0.02 mg (Yeast)
Recombinant Pelotomaculum thermopropionicum LexA repressor (lexA)
Ask
View Details MBS1055372-04 0.1 mg (Yeast)
Recombinant Pelotomaculum thermopropionicum LexA repressor (lexA)
Ask
View Details